Detalhe da pesquisa
1.
Transmitted HIV Drug Resistance Is High and Longstanding in Metropolitan Washington, DC.
Clin Infect Dis
; 63(6): 836-843, 2016 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27307507
2.
Early virologic response to abacavir/lamivudine and tenofovir/emtricitabine during ACTG A5202.
HIV Clin Trials
; 14(6): 284-91, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24334181
3.
HIV-1 amino acid changes among participants with virologic failure: associations with first-line efavirenz or atazanavir plus ritonavir and disease status.
J Infect Dis
; 206(12): 1920-30, 2012 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23148287
4.
Panel of prototypical recombinant infectious molecular clones resistant to nevirapine, efavirenz, etravirine, and rilpivirine.
Antimicrob Agents Chemother
; 56(8): 4522-4, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22664973
5.
The Effect of Physical Exercise After a Concussion: A Systematic Review and Meta-analysis.
Am J Sports Med
; 46(3): 743-752, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28570092
6.
Assessment of Prevention of Mother-to-Child Transmission HIV Services in the Bantey Meanchey Province in Cambodia.
J Int Assoc Provid AIDS Care
; 15(4): 345-9, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26337679
7.
Treatment failure and drug resistance in HIV-positive patients on tenofovir-based first-line antiretroviral therapy in western Kenya.
J Int AIDS Soc
; 19(1): 20798, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27231099
8.
HIV drug resistance mutations in proviral DNA from a community treatment program.
PLoS One
; 10(1): e0117430, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25635815
9.
HIV diversity and drug resistance from plasma and non-plasma analytes in a large treatment programme in western Kenya.
J Int AIDS Soc
; 17: 19262, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25413893
10.
Detection of HIV-1 in Saliva: Implications for Case-Identification, Clinical Monitoring and Surveillance for Drug Resistance.
Open Virol J
; 4: 88-93, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-21673840
11.
Switch from enfuvirtide to raltegravir in virologically suppressed HIV-1 infected patients: effects on level of residual viremia and quality of life.
J Clin Virol
; 46(4): 305-8, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19819183